A familiar skin-care routine can become difficult to plan when a client is undergoing cancer treatment. The person may report new discomfort, a change in product tolerance, or restrictions from their medical team. Cancer treatments can cause dryness, itching, rash, and other skin changes that warrant communication with the treating team. For an esthetician, these circumstances change the questions that need to be asked before an elective service begins.[1]
The professional task is limited but meaningful: understand the information relevant to the appointment, describe what is visible without diagnosing, recognize the limits of the service, and decide whether to proceed, modify, postpone, or refer. The Kosichenko Oncology Barrier Index, or K-OBI, was developed around that task.[2]
The background to K-OBI begins with Anna Kosichenko’s work in Tampa Bay. In April 2025, she opened Hush & Glow Advanced Facial Bar. In June of that year, she began charitable oncology-supportive facial events for people undergoing or recovering from cancer treatment. Further events followed in October 2025 and February 2026.
The charitable work provided an important source of inspiration for her professional education initiative. An appointment could offer time, attention, and an opportunity to discuss everyday skin-care concerns. It also required the practitioner to recognize when a familiar service sequence was unsuitable and when the limits of an elective appointment needed to be explained.
The educational question became broader than product selection. What information belongs in the consultation? How should a practitioner record a client’s discomfort alongside visible observations? When should an appointment be simplified, postponed, or stopped? How can that reasoning be taught to another professional?
These questions helped shape H&G Advanced Skin Institute and the development of K-OBI. The history describes the practice context behind the framework. The charitable appointments were not a clinical trial and are not presented as evidence that K-OBI improves medical outcomes.
How the framework developed
K-OBI is an authored, provisional esthetic screening and decision-support framework. Its purpose is to organize a narrow decision about non-medical care at a particular appointment. It does not determine the cause of a skin change or assign a medical toxicity grade.[2]
The framework brings together relevant treatment context reported by the client, current skin discomfort, visible barrier-related findings, product tolerance, and service-related considerations. These elements are connected to conservative service planning and documentation. The client’s report is considered alongside what the practitioner can see.
A central feature is the separation of screening from routine protocol selection. K-OBI begins with a stop screen and includes rules that take priority over a numerical result. A concern that requires postponement is not intended to disappear within an otherwise reassuring total. The framework’s Safety Hold pathway makes the decision not to perform hands-on care explicit.[2]
The public value of this structure is educational: it gives a learner a sequence to discuss, practice, and document. Whether the framework produces sufficiently consistent and useful decisions across different users requires formal evaluation.
Oncology-supportive education and medical systems for assessing treatment-related skin effects already exist. K-OBI should be understood in that context. It makes an authored contribution to the organization of a specific esthetic workflow rather than establishing that earlier professionals lacked methods or relied only on intuition.
The framework links consultation, observation, limitations on service intensity, an explicit hold decision, and written reasoning. In an educational setting, the learner is asked to explain why a step is appropriate, what information is missing, and what would require the decision to change.
This supports a competency-based approach to learning. Naming a skin-care ingredient or repeating a protocol is insufficient if the practitioner cannot recognize when the protocol should not be used. The intended competence includes restraint, communication, and the ability to identify a question that exceeds esthetic scope.
The Institute’s second Zenodo work addresses epidermal growth factor receptor inhibitor-associated papulopustular eruptions and their relationship to acne-like and rosacea-like presentations. It uses that topic to examine the limits of visual assumptions in esthetic practice.[3]
The educational point is not to ask an esthetician to identify the correct medical diagnosis. It is to examine how relevant treatment history, the timing of a change, the client’s report, and uncertainty should influence the decision about an elective service. Familiar-looking findings should not automatically trigger a familiar procedure.
Within this approach, descriptive documentation has a defined role. A practitioner can record what the client reported, what was observed, which information remains uncertain, and why the appointment was modified or postponed. Determining the cause and medical management of a treatment-related eruption belongs to the treating clinician.[3]
From practice to education
The Institute’s educational history includes in-person and online workshops for licensed professionals and sessions with beauty schools. Oncology-supportive esthetics remains its most developed educational focus, with K-OBI serving as its leading framework.
The platform now follows a defined publication policy: courses are listed and opened for enrollment only after continuing education approval has been confirmed for the specific course and delivery format. Previously delivered workshops remain part of the Institute’s history and are not retrospectively presented as CE-approved activities.
The broader Institute concept extends to complex and sensitive client needs. Additional pathways in development address sensory preferences, medication-related service questions, reactive skin, healing concerns, fragile skin, hormonal transitions, and recent procedures. Their shared educational purpose is to help practitioners recognize when a routine approach needs reconsideration.
This expansion does not make K-OBI a general diagnostic tool or establish completed training in every subject. It reflects a direction for educational development: clear questions, explicit limitations, practical decision-making, and respectful communication.
Evidence and further development
The first Zenodo publication describes K-OBI’s conceptual structure and evaluation priorities. The second explores a defined practice question through the framework. These works make the author’s reasoning available for reading and discussion.[2][3]
The scientific literature informing a framework does not automatically validate the framework’s original design. K-OBI’s rules, weights, and thresholds remain provisional. Evaluation should examine whether the language is understandable, whether trained users reach consistent decisions, how the workflow functions in practice, and whether its proposed decision boundaries are supported by evidence.[2]
A DOI provides a persistent reference to a work. Repository publication alone does not establish journal peer review or clinical effectiveness. Likewise, the number of appointments or learners reached cannot substitute for a study designed to evaluate the framework.
K-OBI developed from the meeting point of charitable practice, professional questions, and educational development. Its intended contribution is a structured way to organize the esthetician’s reasoning, including the decision that no hands-on service should be performed at that time.
For H&G Advanced Skin Institute, the continuing task is to connect practical learning with transparent evidence, independent scrutiny, and respect for professional boundaries. The community work that helped inspire the Institute remains part of that purpose: listening carefully to people whose needs require more than a routine response.
Author disclosure
Anna Kosichenko developed K-OBI and founded H&G Advanced Skin Institute. This article describes the history and intended educational use of her framework. The account of the Institute’s development is based on the founder’s professional history. It reports no original clinical study or patient outcome dataset.
References
- National Cancer Institute. Skin and Nail Changes during Cancer Treatment.
- Kosichenko A. The Kosichenko Oncology Barrier Index (K-OBI): An Evidence-Informed Esthetic Decision-Support Framework for Skin Barrier Screening During Active Cancer Treatment. Zenodo; 2026. Preprint/conceptual framework. doi:10.5281/zenodo.22714343.
- Kosichenko A. Recognizing EGFR Inhibitor-Associated Papulopustular Eruptions: Distinguishing Treatment-Related Findings From Acne and Papulopustular Rosacea Within the K-OBI Esthetic Screening Framework. Zenodo; 2026. Preprint/practice review. doi:10.5281/zenodo.22715000.
Educational information only. K-OBI does not provide a medical diagnosis, determine medical fitness, or replace the client’s healthcare team. Its use does not expand a professional license or permitted scope.